Association between Homocysteine and Vitamin D Levels in Asymptomatic Korean Adults.
Yun-Ah LeeSung-Goo KangSang-Wook SongSe-Hong KimPublished in: Nutrients (2024)
An increased homocysteine level is a risk factor for cardiovascular disease, venous thromboembolism, cerebrovascular disease, and chronic kidney disease. In addition, vitamin D deficiency is associated with coronary artery disease and metabolic disorders. The present study included data from 1375 adults (895 men and 480 women) with a mean age of 52.62 ± 9.94 years who visited the Health Promotion Center of the University Hospital in Gyeonggi-do, Republic of Korea from January 2018 to December 2022 for routine checkups that included assessments of their homocysteine and vitamin D levels. Homocysteine levels were positively associated with age, a history of hypertension, a history of diabetes, current smoking habits, and levels of low-density lipoprotein cholesterol, creatinine, uric acid, and high-sensitivity C-reactive protein. By contrast, vitamin D levels were negatively associated with serum levels of homocysteine after adjusting for covariates ( β = -0.033, p < 0.001). Additional long-term prospective studies are needed to elucidate the presence of a causal relationship between vitamin D status and serum levels of homocysteine in asymptomatic Korean adults. An intervention trial is warranted to determine whether the administration of vitamin D is helpful for the primary prevention of cardiovascular disease by lowering the homocysteine level in this population.
Keyphrases
- cardiovascular disease
- uric acid
- coronary artery disease
- venous thromboembolism
- type diabetes
- randomized controlled trial
- blood pressure
- magnetic resonance imaging
- magnetic resonance
- clinical trial
- cardiovascular events
- machine learning
- percutaneous coronary intervention
- acute coronary syndrome
- atrial fibrillation
- big data
- coronary artery bypass grafting
- end stage renal disease
- cardiovascular risk factors
- skeletal muscle
- glycemic control
- open label
- peritoneal dialysis
- artificial intelligence